IMV Inc. (IMVIQ) Stock Analysis
DELISTED
What happened to IMV Inc. (IMVIQ) stock?
IMV Inc. (IMVIQ) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
IMV Inc. (IMVIQ). IMV Inc. is a clinical-stage immuno-oncology company focused on developing DPX-based therapies for solid and hematological cancers. Their lead drug candidate, maveropepimut-S, is undergoing clinical trials for various cancers.
Last analyzed: Mar 16, 2026IMV Inc. (IMVIQ) Healthcare & Pipeline Overview
IMVIQ OTC Market Information
IMVIQ trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy IMVIQ shares?
No. IMVIQ stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for IMVIQ elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before IMVIQ stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to IMV Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.